Characterization of human A(2A) adenosine receptors with the antagonist radioligand [3H]-SCH 58261

British Journal of Pharmacology

Volumn 121, Issue 3, 1997, Pages 353-360

  Dionisotti, Silvio ^a   Ongini, Ennio ^a   Zocchi, Cristina ^a   Kull, Björn ^b   Arslan, Giulia ^b   Fredholm, Bertil B ^b  

^a Schering Plough Research Institute   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

3H SCH 58261; A(2A) receptor antagonists; Adenosine receptors; Human A(2A) receptors; Non xanthine adenosine receptor antagonists

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 ANILINOADENOSINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 7 (2 PHENYLETHYL) 2 (2 FURYL) PYRAZOLO[4,3] 1,2,4 TRIAZOLO[1,5]PYRIMIDINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYCLOHEXYLADENOSINE; PHENYLISOPROPYLADENOSINE; RADIOLIGAND; THEOPHYLLINE; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CHO CELL; COMPETITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; GENETIC TRANSFECTION; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING; THROMBOCYTE; ANIMAL; BINDING COMPETITION; BIOSYNTHESIS; DRUG ANTAGONISM; HAMSTER; HUMAN; METABOLISM; RADIOASSAY; RAT; SPECIES DIFFERENCE;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC AMP; HUMANS; PYRIMIDINES; RADIOLIGAND ASSAY; RATS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; SPECIES SPECIFICITY; TRANSFECTION; TRIAZOLES;

EID: 0030610297     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701119     Document Type: Article

References (36)

1. 2A adenosine receptor antagonists. Bioorg. Med. Chem. Lett., 4, 2539-2544.
2. 2A adenosine receptor antagonist. J. Labelled Compd. Rad., 38, 725-732.
3. 3H]SCH 58261 to coronary artery membranes. Circ. Res., 79, 1153-1160.
4. 2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 64-69.
5. 3H]NECA in rat striatal membranes. Mol. Pharmacol., 29, 331-346.
6. 1 receptor. Br. J. Pharmacol., 117, 1521-1529.
7. 2 adenosine receptors. J. Med. Chem., 35, 2365-2368.
8. 2A receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 261-271.
9. 3H]SCH 58261. J. Pharmacol. Exp. Ther., 278, 1209-1214.
10. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
11. 2 receptor. Mol. Brain Res., 15, 62-66.
12. GILMAN, A.G. (1987). G-proteins: transducer of receptor-generated signals. Annu. Rev. Biochem., 56, 615-649.
13. GURDEN, M.F., COATES, J., ELLIS, F., EVANS, B., FOSTER, M., HORNBY, E., KENNEDY, I., MARTIN, D.P., STRONG, P., VARDEY, C.J. & WHEELDON, A. (1993). Functional characterization of three adenosine receptor types. Br. J. Pharmacol., 109, 693-698.
14. 2 selective receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther., 251, 47-55.
15. JACOBSON, M.A. (1995). Molecular biology of adenosine receptors. In Adenosine and Adenine Nucleotides. ed. Belardinelli, L. & Pelleg, A. pp. 5-13. Boston: Kluwer Academic Publishers.
16. 2 receptors in rat brain. J. Pharmacol. Exp. Ther., 251, 888-893.
17. 2 receptors in rat striatum. Biochem. Pharmacol., 44, 2365-2370.
18. 3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur. J. Pharmacol. Mol. Pharmacol. Sect., 247, 103-110.
19. 2A receptors. Pharmacol. Toxicol., 76, Suppl. II, P1.26.
20. 3H]-CGS 21680 in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 539-541.
21. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.I. & RANDALL, R.J. (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem., 193, 265-275.
22. 125I]iodophenyl)ethyl-amino]adenosine. Mol. Pharmacol., 47, 307-313.
23. MUNSON, P.J. & RODBARD, P. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
24. 2 receptor antagonist, to rat brain membranes. Mol. Pharmacol., 48, 817-822.
25. NORDSTEDT, C. & FREDHOLM, B.B. (1990). A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluids. Anal. Biochem., 189, 231-234.
26. 2A receptors. Trends Pharmacol. Sci., 17, 364-372.
27. 2A adenosine receptor. Mol. Pharmacol., 48, 970-974.
28. 3H]CGS 21680 as radioligand. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 85-89.
29. 2 receptors: a quantitative autoradiographical study. Mol. Neuropharmacol., 1, 179-186.
30. 2 adenosine receptors. Int. J. Purine Pyrimidine Res., 3, 82.
31. 2 antagonists. J. Med. Chem., 35, 2342-2345.
32. STILES, G.L. & JACOBSON, K.A. (1987). A new high affinity, iodinated adenosine receptor antagonist as a radioligand/ photoaffinity crosslinking probe. Mol. Pharmacol., 32, 184-188.
33. 2 receptor binding in striatal membranes from mammalian brain. Drug Dev. Res., 15, 31-46.
34. 2A receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 250-260.
35. 3H]-CGS 21680 in human platelets. Biochem. Pharmacol., 48, 1658-1661.
36. 2A adenosine receptor antagonist, to rat striatal membranes. Br. J. Pharmacol., 117, 1381-1386.